BioMedNewsBreaks – HealthLynked Corp. (HLYK) Announces Q2, H1 2024 Financial Results Reflecting Efforts to Streamline Operations

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced financial results for its Q2 and H1 2024 ending June 30, 2024. The announcement noted that the company achieved significant cost reductions, leading to an 8% quarter-over-quarter improvement in its loss from operations to $1.08 million in Q2 2024 from $1.18 million in Q1 2024. […]